Literature DB >> 32216949

Co-Occurring LKB1 Deficiency Determinates the Susceptibility to ERK-Targeted Therapy in RAS-Mutant Lung Cancer.

Haitang Yang1.   

Abstract

Entities:  

Year:  2020        PMID： 32216949     DOI： 10.1016/j.jtho.2020.01.004

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  1 in total

1.  Liver Kinase B1 (LKB1) Regulates Proliferation and Apoptosis of Non-Small Cell Lung Cancer A549 Cells via Targeting ERK Signaling Pathway.

Authors:  Yirong Wang; Lei Yang; Yan Yang; Yulin Li
Journal:  Cancer Manag Res       Date:  2021-01-07       Impact factor: 3.989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.